Litigation Details for Twin City Iron Workers Health And Welfare Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
✉ Email this page to a colleague
Twin City Iron Workers Health And Welfare Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-22 |
| Court | District Court, D. Connecticut | Date Terminated | 2018-08-10 |
| Cause | MDL 2516 In Re: Aggrenox Antitrust Litigation | Assigned To | Stefan R. Underhill |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,015,577 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Twin City Iron Workers Health And Welfare Fund v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Twin City Iron Workers Health And Welfare Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-04-01 | 1 | . Boehringer submitted Patent No. 6,015,577 (the "'577 Patent") to the FDA for listing… ‘577 Patent, asserting that its generic would not infringe the patents and/or that the patents were … (but not necessarily) covered by patents, which provide the patent owner with the exclusive right to…the duration of the patents involved, plus any extension of the original patent period (the “FDA Exclusivity…claim of patent infringement could reasonably be asserted. “Prior art” is the term used in patent law to | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
